Santé Ventures overview
Stories about Santé Ventures
Santé Ventures names senior associate
Austin-based Santé Ventures, a healthcare and life sciences investment firm, has appointed Eric Epstein as senior associate. Previously, he worked at McKinsey & Company where he was an engagement manager.
Santé Ventures taps McWilliams as venture partner
Austin-based Santé Ventures, a healthcare and life sciences investment firm, has appointed Dennis McWilliams as a venture partner. McWilliams is the founder of SparkMed Advisors.
RiverVest, Sante, Third Point Ventures lead funding in Lyric Pharmaceuticals
RiverVest Venture Partners, Sante Ventures and Third Point Ventures have co-led an initial close of a $20.4 million Series A funding round in Lyric Pharmaceuticals Inc, a clinical stage company developing therapeutics for gastrointestinal disease. Lyric closed an $825,000 seed funding round led by RiverVest last year.
Lumos Pharma raises $14 mln in Series A funding
Lumos Pharma, an early stage biopharmaceutical company, has raised $14 million in Series A funding. The round was co-led by Sante Ventures and New Enterprise Associates.
VC-backed Molecular Templates garners $8.5 mln in Series C financing
Molecular Templates said Tuesday that it has raised $8.5 million in Series C financing. Excel Venture Management was the lead investor. Existing investor Santé Ventures also participated in the round. Concurrent with the funding, Excel's Dr. Steven Gullans and Caleb Winder join Molecular's board of directors. Based in Georgetown, Texas, Molecular Templates is a biopharmaceutical company focused on developing new biologic therapeutics.
TVA Medical Raises $9.5 Mln
TVA Medical said Monday that raised $9.5 million in series B financing led by S3 Ventures. TriStar Technology Ventures and existing investor, Santé Ventures also participated. Austin-based TVA is a medical device company.
Spinal Restoration Closes $5 Mln Debt, Equity Round
Spinal Restoration said Monday it closed a $5 million financing round, which includes $3 million equity from current investors Austin Ventures, Sante’ Ventures, and MB Venture Partners. Comerica Bank is also providing a $2 million debt facility. Austin-based Spinal Restoration is trying to gain regulatory approval of its Biostat System, a drug used to treat chronic disc pain.
Santé Ventures contact information
Offices
1300 Red River Street, Suite 1500, Austin, 78701, United StatesContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Mr. Kevin M Lalande | Job titleFounding Managing Director and Chief Investment Officer | LocationAustin, United States | Email  -------- |
| Mr. Jason Brandt | Job titleChief Financial Officer and Chief Compliance Officer | LocationAustin, United States | Email ------- |
| Mr. Casey Cunningham | Job titlePartner and Chief Scientific Officer | LocationBoston, United States | Email ----------- |
| Mr. Joe Cunningham | Job titleFounding Managing Director | LocationAustin, United States | Email -------- |
Santé Ventures funds managed
Closed funds: 6
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size ------- | Close dateFeb 2026 | Strategy ------- | |
Fund size ----------- | Close dateSep 2021 | Strategy ---------- | |
Fund size ---------- | Close dateMay 2019 | Strategy ------ | |
Stories that mention Santé Ventures
Surgical Safety Technologies lands $15m in Series A financing
Based in Toronto, Surgical Safety Technologies is a medical technology company that engineered the OR Black Box, a platform for improving patient safety.
Venture capital’s 2023 Rising Stars (1 of 4)
Ibrahim AlSuwaidi, Rosalind Bazany, Jean-François Cochy and Kareem Dabbagh are among the 40 Rising Stars under the age of 40 in Venture Capital Journal's fourth consecutive list.
Endeavour Vision leads $25 mln Series D in EndoStim
Endeavour Vision led a $25 million Series D financing round in EndoStim, Inc., a medical device company with a neurostimulation therapy for acid reflux. The treatment is currently available in Europe, Latin America, and Asia Pacific, but has not been approved for sale in the U.S. The funding will go in part towards clinical trials. New investors Wellington Partners and Gimv also participated in the funding.
Laguna Pharmaceuticals grabs $30 mln Series B, also appoints CEO
Laguna Pharmaceuticals, formerly known as ChanRx, has closed $30 million in Series B financing. Versant Ventures and Frazier Healthcare led the round with participation from BioMed Ventures and previous backer Sante Ventures. In addition to the financing, Dr. Jerel Davis of Versant Ventures and Dr. Jamie Topper of Frazier Healthcare have been added to Laguna's board of directors. Also, Laguna Pharmaceuticals has hired Bob Baltera as CEO. Previously, Baltera was CEO of Amira Pharmaceuticals. Laguna Pharmaceuticals is a biopharmaceutical company focused on treating atrial fibrillation and atrial flutter.
Molecular Templates grabs $3.5 mln Series C
Molecular Templates has secured an additional $3.5 million in Series C funding from AJU IB Investment. In conjunction with the funding, Timothy Sullivan, a partner at AJU Life Sciences Overseas Expansion Platform Fund, has been added to the firm's board of directors. Based in Georgetown, Texas, Molecular Templates is a biopharmaceutical firm that focuses on developing the next generation of immunotoxins.
Slideshow: Top 10 Largest VC Funds Raised in Q1
As we reported earlier today /100782/giant-funds-from-bessemer-sequoia-and-kp-help-produce-biggest-quarter-for-vc-fundraising-since-q3-2008/ VC fundraising roared back in Q1, with U.S. VC funds raising their largest amount since the third quarter of 2008. Bessemer Venture Partners led the pack, raising a monster fund of $1.6 billion. Who else is in the top 10? Click through to check out our slideshow /100788/slideshow-top-10-largest-vc-funds-raised-in-q1/